|
Effects of an intensive dynamic exercise program on the outcome of patients with rheumatoid arthritis. Benha faculty of Medicine. 22 (1): 843-856.
|
|
|
Anticyclic citrulinated peptide antibodies: Role in the diagnosis of rheumatoid arthritis and differentiation from patients with chronic hepatitis C virus infection with articular manifestations. The Egyptian rheumatologist, 29 (1): 213-221.
|
|
|
Clinical Association and value of antineutrophil cytoplasmic antibodies immunofluorcent patient in Juvenile Rheumatoid Arthritis. The Egyptian Rheumatologist, 29 (1): 323-333.
|
|
|
Value of cartilage oligomeric matrix protein and YKL-40 as biochemical markers in patients with knee osteoarthritis, 29 (2): 105-113.
|
|
|
Intima Media thickness of the common carotid artery in patients with rheumatoid arthritis. Egyptian Rheumatology and Rehabilitation Accepted, 34 (3).
|
|
|
Detection of carotid athresclerosis in SLE and its relation to risk factor. Egyptian Rheumatology and Rehabilitation Accepted, 34 (4).
|
|
|
Potential role of calprotectin as a monitoring biomarker for clinical, sonographic activity and treatment outcome in recent onset rheumatoid arthritis
|
|
|
IMPACT OF AN INTENSIVE DYNAMIC EXERCISE PROGRAM ON OXIDATIVE STRESS AND ON THE OUTCOME IN PATIENTS WITH FIBROMYALGIA
|
|
|
Assessment of the implication of epidural steroid injection versus other conservative measures in the management of lumbar disc herniation
|
|
|
MAGNETIC RESONANCE IMAGING IN KNEE OSTEOARTHRITIS: CORRELATION WITH other VARIABLES
|
|
|
Clinical Associations and Role of Serum Level of
A Proliferation Inducing Ligand in Patients.with Systemic Lupus Erythmatosus
|
|
|
Role of Anti-nucleosome Antibodies in the Diagnosis of Systemic Lupus Erythematosus and as A Marker for Lupus Nephropathy
|
|
Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis
|
|
HLA-DRB1 alleles in Egyptian rheumatoid arthritis patients: relations to anti-cyclic citrullinated peptide antibodies, disease activity and severity
|
|